Clinical Trials in Virginia (VA) | Virginia Clinical Drug Trials & Studies

You are viewing Clinical Trials In Virginia

Have multiple conditions? Click here

Showing 1-100 of 1379

There are 1379 trials in Virginia

Name	City	State	Zip
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer	Woodbridge	VA	22191
Phase II Avastin Trial for Stage IIIB/IV NSCLC	Woodbridge	VA	22191
The Dual Antiplatelet Therapy Study (DAPT Study)	Winchester	VA	22604
Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)	Winchester	VA	22604
Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies	Winchester	VA	22601
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy	Winchester	VA	22601
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication	Winchester	VA	22601
Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study	Williamsburg	VA
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function	Virginia Beach	VA	23454
The INFUSE - Anterior Myocardial Infarction (AMI) Study	Virginia Beach	VA	23454
A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) in Advanced Parkinson's Disease	Virginia Beach	VA	23456
The Dual Antiplatelet Therapy Study (DAPT Study)	Virginia Beach	VA	23454
PRE-DETERMINE Cohort Study	Virginia Beach	VA	23454
A Multicenter Study to Evaluate the Efficacy of DR-105 for Menstrually-Related Migraine Headaches	Virginia Beach	VA	23454
Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis	Virginia Beach	VA	23454
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)	Virginia Beach	VA	23454
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study	Virginia Beach	VA	23462
Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the BiostatÂ® System	Virginia Beach	VA	23454
Safety and Efficacy of F2695 SR in Major Depressive Disorder	Virginia Beach	VA	23452
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease	Virginia Beach	VA
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder	Virginia Beach	VA	23452
Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)	Virginia Beach	VA	23452
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)	Virginia Beach	VA	23454
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease	Virginia Beach	VA	23456
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study	Virginia Beach	VA
Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)	Virginia Beach	VA	23456
Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails	Virginia Beach	VA	23464
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder	Virginia Beach	VA	23456
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants	Vienna	VA	22180
A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo	Vienna	VA
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta	Vienna	VA	22182
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus	Suffolk	VA	23435
Topical Antimicrobial Effectiveness Testing	Sterling	VA	20164
Replagal Enzyme Replacement Therapy for Children With Fabry Disease	Stafford	VA	22556
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Stafford	VA	22554
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Stafford	VA	22554
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Stafford	VA	22554
Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain	Stafford	VA	22554
A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer	Stafford	VA	22554
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer	Stafford	VA	22554
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Stafford	VA	22554
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer	Stafford	VA	22554
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma	Stafford	VA	22554
Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease	Springfield	VA	22152
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease(ENGAGE)	Springfield	VA	22152
Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease	Springfield	VA	22152
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)	Springfield	VA	22152
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis	Springfield	VA	22152
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model	Springfield	VA	22152
Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease	Springfield	VA	22152
Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease	Springfield	VA	22152
A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease	Springfield	VA	22152
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants	Springfield	VA	22150
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor	Salem	VA	24153
Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma	Salem	VA	24153
Gemzar, Cisp, Sunitinib Urothelial Ca	Salem	VA	24153
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial	Salem	VA	24153
Welchol as Monotherapy for Type 2 Diabetes Mellitus	Salem	VA	24153
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus	Salem	VA	24153
Extended Steroid in CAP(e)	Salem	VA	24153
A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer	Salem	VA	24153
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy	Salem	VA	24153
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)	Salem	VA	24153
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy	Salem	VA	24153
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma	Roanoke	VA	24014
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors	Roanoke	VA	24014
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Roanoke	VA	24014
Study of Late-Occurring Complications in Childhood Cancer Survivors	Roanoke	VA	24014
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Roanoke	VA	24014
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors	Roanoke	VA	24014
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Roanoke	VA	24014
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes	Roanoke	VA	24014
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia	Roanoke	VA	24014
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor	Roanoke	VA	24014
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	Roanoke	VA	24014
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Roanoke	VA	24014
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Roanoke	VA	24014
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Roanoke	VA	24014
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma	Roanoke	VA	24014
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer	Roanoke	VA	24014
Study of Kidney Tumors in Young Patients	Roanoke	VA	24014
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma	Roanoke	VA	24014
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma	Roanoke	VA	24014
Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma	Roanoke	VA	24014
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma	Roanoke	VA	24014
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	Roanoke	VA	24014
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors	Roanoke	VA	24014
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Roanoke	VA	24014
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia	Roanoke	VA	24014
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia	Roanoke	VA	24016
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels	Roanoke	VA	24016
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer	Roanoke	VA	24016
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	Roanoke	VA	24016
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Roanoke	VA	24016
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Roanoke	VA	24016
Collecting Tumor Samples From Patients With Gynecological Tumors	Roanoke	VA	24016
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	Roanoke	VA	24016
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Roanoke	VA	24016
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer	Roanoke	VA	24016
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	Roanoke	VA	24016

View Clinical Trial Facilities in Virginia

Showing 1-100 of 1379